Lab
Hancock Health Gateway Services, INC.
Hancock Health Gateway Services, INC. was paid $127K by Medicaid between Feb 2020 and Nov 2024, across 23 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 16% of everything it billed.
33Billing provider infoHANCOCK HEALTH GATEWAY SERVICES, INC.
GREENFIELD, IN 46140
GREENFIELD, IN 46140
33aNPI1659848521assigned 10/30/2018
33bProvider typeClinical Medical Laboratory
28Total paid$127K
24GClaims17,077
24DCodes billed23
24AFirst – last monthFeb 2020 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Indiana
Rank by total paid#29 of 66
Median peer was paid$53K
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,264 | $9K | |
| 2021 | 3,240 | $28K | |
| 2022 | 3,384 | $27K | |
| 2023 | 4,082 | $22K | |
| 2024incomplete | 5,107 | $40K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 16% | 2,134 | 1,767 | $21K |
| 80053 | Comprehensive metabolic panel | 12% | 2,562 | 2,048 | $15K |
| 80061 | Lipid panel | 12% | 1,847 | 1,544 | $15K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 12% | 348 | 313 | $15K |
| 36415 | Collection of venous blood by venipuncture | 11% | 4,242 | 3,262 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.0% | 2,504 | 1,945 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.1% | 200 | 121 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.7% | 237 | 210 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.3% | 836 | 685 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.7% | 194 | 161 | $3K |
| 87088 | 2.0% | 561 | 472 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.6% | 85 | 79 | $2K |
11 more codes
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.6% | 85 | $2K |
| 84439 | 1.5% | 290 | $2K | |
| 82607 | 1.0% | 136 | $1K | |
| 87081 | <1% | 197 | $801.96 | |
| 85027 | <1% | 136 | $583.13 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 40 | $548.17 |
| 82728 | <1% | 30 | $248.87 | |
| 84153 | <1% | 12 | $183.90 | |
| 82043 | <1% | 28 | $101.48 | |
| 82570 | <1% | 17 | $44.28 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 356 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLONG, STEVEN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Hancock Regional Hospital | Indianapolis, IN | $744K |
| Hancock Health Gateway Services, INC. | Greenfield, IN | $144K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.